These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26939486)

  • 1. [Inflammation and cancer - colorectal carcinoma as an example].
    Väyrynen J; Böhm J
    Duodecim; 2016; 132(2):137-44. PubMed ID: 26939486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordination of intratumoral immune reaction and human colorectal cancer recurrence.
    Camus M; Tosolini M; Mlecnik B; Pagès F; Kirilovsky A; Berger A; Costes A; Bindea G; Charoentong P; Bruneval P; Trajanoski Z; Fridman WH; Galon J
    Cancer Res; 2009 Mar; 69(6):2685-93. PubMed ID: 19258510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor and its relationship to inflammatory mediators.
    Angelo LS; Kurzrock R
    Clin Cancer Res; 2007 May; 13(10):2825-30. PubMed ID: 17504979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host response to colorectal cancer.
    Salama P; Platell C
    ANZ J Surg; 2008 Sep; 78(9):745-53. PubMed ID: 18844901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.
    Cathcart MC; Lysaght J; Pidgeon GP
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):363-85. PubMed ID: 22134655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical utility of the local inflammatory response in colorectal cancer.
    Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis.
    Ribatti D
    Immunol Lett; 2013 May; 152(2):83-8. PubMed ID: 23685256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis and the immune response as targets for the prevention and treatment of colorectal cancer (review).
    Sharma RA; Dalgleish AG; Steward WP; O'Byrne KJ
    Oncol Rep; 2003; 10(5):1625-31. PubMed ID: 12883750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis, immune system and growth factors: new targets in colorectal cancer therapy.
    Fantini MC; Becker C; Neurath MF
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):681-94. PubMed ID: 16111468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma.
    Liu J; Duan Y; Cheng X; Chen X; Xie W; Long H; Lin Z; Zhu B
    Biochem Biophys Res Commun; 2011 Apr; 407(2):348-54. PubMed ID: 21396350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
    Chaux P; Moutet M; Faivre J; Martin F; Martin M
    Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and colorectal cancer.
    Kraus S; Arber N
    Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer?
    Guthrie GJ; Roxburgh CS; Horgan PG; McMillan DC
    Cancer Treat Rev; 2013 Feb; 39(1):89-96. PubMed ID: 22858249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation in sporadic colorectal cancer.
    Moossavi S; Bishehsari F
    Arch Iran Med; 2012 Mar; 15(3):166-70. PubMed ID: 22369306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
    Roxburgh CS; McMillan DC
    Cancer Treat Rev; 2012 Aug; 38(5):451-66. PubMed ID: 21945823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma.
    Kuang DM; Zhao Q; Wu Y; Peng C; Wang J; Xu Z; Yin XY; Zheng L
    J Hepatol; 2011 May; 54(5):948-55. PubMed ID: 21145847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and cancer: the role of the immune response and angiogenesis.
    Dalgleish AG; O'Byrne K
    Cancer Treat Res; 2006; 130():1-38. PubMed ID: 16610701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies.
    Atreya I; Neurath MF
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):561-72. PubMed ID: 18402523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor proangiogenic signaling in cancer progression.
    Schaffner F; Yokota N; Ruf W
    Thromb Res; 2012 Apr; 129 Suppl 1():S127-31. PubMed ID: 22682123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.